Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3

Genes and Development

Volumn 9, Issue 21, 1995, Pages 2635-2645

  Yuan, Huabing ^a,c   Corbi, Nicoletta ^a,d   Basilico, Claudio ^a   Dailey, Lisa ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

FGF 4 expression; mouse embryogenesis; Oct proteins; Sox factors

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BLASTOCYST; DNA SEQUENCE; EMBRYO; EMBRYO DEVELOPMENT; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE TARGETING; GROWTH REGULATION; LIMB DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0028808183     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.9.21.2635     Document Type: Article

References (52)

1. Basilico, C. and D. Moscatelli. 1992. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59: 115-163.
2. Berta, P., J.R. Hawkins, A.H. Sinclair, A. Taylor, B.L. Griffiths, P.N. Goodfellow, and M. Fellous. 1990. Genetic evidence equating SRY and the testis-determining factor. Nature 348: 448-450.
3. Carlsson, P., M.L. Waterman, and K.A. Jones. 1993. The hLEF/ TCF-1α HMG protein contains a context-dependent transcriptional activation domain that induces the TCRα enhancer in T cells. Genes & Dev. 7: 2418-2430.
4. Curatola, A.M. and C. Basilico. 1990. Expression of the K-fgf proto-oncogene is controlled by 3′ regulatory elements which are specific for embryonal carcinoma cells. Mol. Cell. Biol. 10: 2475-2484.
5. Dailey, L., H. Yuan, and C. Basilico. 1994. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol. Cell. Biol. 14: 7758-7769.
6. Delli Bovi, P., A.M. Curatola, F.G. Kern, A. Greco, M. Ittmann, and C. Basilico. 1987. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50: 729-737.
7. Denny, P., S. Swift, F. Connor, and A. Ashworth. 1992. An SRY-related gene expressed during spermatogenesis in the mouse encodes a sequence-specific DNA binding protein. EMBO J. 11: 3705-3712.
8. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
9. Du, H., A.L. Roy, and R.G. Roeder. 1993. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12: 501-511.
10. Feldman, B., W. Poueymirou, V.E. Papaioannou, T.M. DeChiara, and M. Goldfarb. 1995. Requirement of FGF-4 for post-implantation mouse development. Science 267: 246-250.
11. Ferrari, S., V.R. Harley, A. Pontiggia, P.N. Goodfellow, R. Lovell-Badge, and M.E. Bianchi. 1992. SRY, like HMG 1, recognizes sharp angles in DNA. EMBO J. 11: 4497-4506.
12. Foster, J.W., M.A. Dominguez-Steglich, S. Guioli, G. Kowk, and P.A. Weller. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372: 525-530.
13. Giese, K. and R. Grosschedl. 1993. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J. 12: 4667-4676.
14. Giese, K., J. Cox, and R. Grosschedl. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185-195.
15. Grosschedl, R., K. Giese, and J. Pagel. 1994. HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures. Trends Genet. 10: 94-100.
16. Gubbay, J., J. Collignon, P. Koopman, B. Capel, A. Economou, A. Munsterberg, N. Vivian, P.N. Goodfellow, and R. Lovell-Badge. 1990. A gene mapping to the sex-determining region of the mouse Y-chromosome is a member of a novel family of embryonically expressed genes. Nature 346: 245-250.
17. Herr, W., R.A. Sturm, R.G. Clerc, L.M. Corcoran, D. Baltimore, P.A. Sharp, H.A. Ingraham, M.G. Rosenfeld, M. Finney, G. Ruvkin, and H.R. Horvitz. 1988. The POU domain: A large conserved region in the mammalian Pit-1, Oct-1, Oct-2, and Caenorhabditis elegans unc-86 gene products. Genes & Dev. 2: 1513-1516.
18. Kamachi, Y., S. Sockanathan, Q. Liu, M. Breitman, R. Lovell-Badge, and H. Kondoh. 1995. Involvement of Sox proteins in lens-specific activation of crystallin genes. EMBO J. 14: 3510-3519.
19. Lai, J.-S., M.A. Cleary, and W. Herr. 1992. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. Genes & Dev. 6: 2058-2065.
20. Laudet, V., D. Stehelin, and H. Clevers. 1993. Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res. 21: 2493-2501.
21. Laufer, E., C.E. Nelson, R.L. Johnson, B.A. Morgan, and C. Tabin. 1994. Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell 79: 993-1003.
22. Luo, Y., H. Fujii, T. Gerster, and R.G. Roeder. 1992. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 71: 231-241.
23. Nasrin, N., C. Buggs, X.F. Kong, J. Carnazza, M. Goebl, and M. Alexander-Bridges. 1991. DNA-binding properties of the product of the testis-determining gene and a related protein. Nature 354: 317-320.
24. Niswander, L. and G.M. Martin. 1992. Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 114: 755-768.
25. Niswander, L., C. Tickel, A. Vogel, I. Booth, and G.R. Martin. 1993. FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb. Cell 75: 579-587.
26. Okamoto, K., H. Okazawa, A. Okuda, M. Sakai, M. Muramatsu, and H. Hamada. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60: 461-472.
27. Pfisterer, P., A. Annweiler, C. Ullmer, L.M. Corcoran, and T. Wirth. 1994. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J. 13: 1655-1663.
28. Pomerantz, J.L., T.M. Kristie, and P.A. Sharp. 1992. Recognition of the surface of a homeo domain protein. Genes & Dev. 6: 2047-2057.
29. Rosner, M.H., M.A. Vigano, K. Ozato, P.M. Timmons, F. Poirer, P.W.J. Rigby, and L.M. Staudt. 1990. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345: 686-692.
30. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. 74: 5463-5467.
31. Schöler, H.R., G.R. Dressler, R. Balling, H. Rohdewold, and P. Gruss. 1990a. Oct-4: A germline specific transcription factor mapping to the mouse t-complex. EMBO J. 9: 2185-2195.
32. Schöler, H.R., R. Siegfried, N. Suzuki, K. Chowdhury, and P. Gruss. 1990b. New type of POU domain in germ line-specific protein Oct-4. Nature 344: 435-439.
33. Schöler, H.R., T. Ciesiolca, and P. Gruss. 1991. A nexus between Oct-4 and E1A: Implications for gene regulation in embryonic stem cells. Cell 66: 291-304.
34. Schoorlemmer, J. and W. Kruijer. 1991. Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells. Mech. Dev. 36: 75-86.
35. Sinclair, A.H., P. Berta, M.S. Palmer, J.R. Hawkins, B.L. Griffiths, D.J. Smith, J.W. Foster, A. Frischaux, R. Lovell-Badge, and P.N. Goodfellow. 1990. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346: 240-244.
36. Staiger, M.G., L. Knoopfel, O. Georgiev, W. Schaffner, and C.M. Hovens. 1995. A B-cell coactivator of octamer-binding transcription factors. Nature 373: 360-362.
37. Stevanovic, M., R. Lovell-Badge, J. Collignon, and P.N. Goodfellow. 1993. SOX3 is an X-linked gene related to SRY. Hum. Mol. Genet. 2: 2013-2018.
38. Strubin, M., J.W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80: 497-506.
39. Taira, M., T. Yoshida, K. Miyagawa, H. Sakamoto, M. Terada, and T. Sugimura. 1987. cDNA sequence of a human transforming gene hst and identification of the coding sequence required for transforming activity. Proc. Natl. Acad. Sci. 84: 2980-2984.
40. Tanaka, M. and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphoryolation. Cell 60: 375-386.
41. Tjian, R. and T. Maniatis. 1994. Transcriptional activation: A complex puzzle with few easy pieces. Cell 77: 5-8.
42. Tommerup, N., W. Schempp, P. Meinecke, S. Pedersen, L. Bolund, C. Brandt, C. Goodpasture, P. Guldberg, K.R. Held, H. Reinwein et al. 1993. Assignment of an autosomal sex reversal locus (SRA1) and campomelic dysplasia (CMPD1) to 17q24.3-q25.1. Nature Genet. 4: 170-174.
43. Travis, A., A. Amsterdam, C. Belanger, and R. Grosschedl. 1991. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor α enhancer function. Genes & Dev. 5: 880-894.
44. Uwanogho, D., M. Rex, E.J. Cartwright, G. Pearl, C. Healy, P.J. Scotting, and P.T. Sharpe. 1995. Embryonic expression of the chicken Sox2, Sox3 and Sox11 genes suggests an interactive role in neuronal development. Mech. Dev. 49: 23-26.
45. van de Wetering, M. and H. Clevers. 1992. Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix. EMBO J. 11: 3039-3044.
46. van de Wetering, M., M. Oosterwegel, K. van Norren, and H. Clevers. 1993. Sox-4 an Sry-like HMG protein, is a transcriptional activator in lymphocytes. EMBO J. 12: 1247-3854.
47. Velcich, A., P. Delli-Bovi, A. Mansukhani, E.B. Ziff, and C. Basilico. 1989. Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Oncogene Res. 5: 31-37.
48. Wagner, T., J. Wirth, J. Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F.D. Bricarelli, J. Keutel, E. Hustert, U. Wolf, N. Tommerup, W. Schemp, and G. Scherer. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79: 1111-1120.
49. Waterman, M. and K. Jones. 1990. Purification of TCF-1α, a T-cell-specific transcription factor that activates the T-cell receptor cα gene enhancer in a context-dependent manner. New Biol. 2: 621-636.
50. Wright, E.M., B. Snopek, and P. Koopman. 1993. Seven new members of the Sox gene family expressed during mouse development. Nucleic Acids Res. 21: 744.
51. Wright, E., M.R. Hargrave, J. Christiansen, L. Cooper, J. Kun, T. Evans, U. Gangadharan, A. Greenfield, and P. Koopman. 1995. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nature Genet. 9: 15-20.
52. Zwilling, S., H. König, and T. Wirth. 1995. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14: 1198-1208.